Cargando…
Changes in the BTK/NF-κB signaling pathway and related cytokines in different stages of neuromyelitis optica spectrum disorders
OBJECTIVE: Neuromyelitis optica spectrum disorders (NMOSDs) are blindness-causing neuritis; their pathogenesis is still not fully elucidated. Although it has been determined that Bruton tyrosine kinase (BTK) and NF-κB are associated with NMOSD, the changes that occur in different periods remain unkn...
Autores principales: | Qiao, Huimin, Mao, Zhuofeng, Wang, Wei, Chen, Xin, Wang, Suhuan, Fan, Haolong, Zhao, Tianyi, Hou, Huiqing, Dong, Mei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9210047/ https://www.ncbi.nlm.nih.gov/pubmed/35729649 http://dx.doi.org/10.1186/s40001-022-00723-x |
Ejemplares similares
-
Treatment of neuromyelitis optica/neuromyelitis optica spectrum disorders with methotrexate
por: Ramanathan, Ramnath Santosh, et al.
Publicado: (2014) -
Neuromyelitis Optica Spectrum Disorder
por: Cazzaniga, Juliana, et al.
Publicado: (2023) -
Neuromyelitis optica spectrum disorders: An update
por: Pandit, Lekha
Publicado: (2015) -
Treatment of Neuromyelitis Optica Spectrum Disorders
por: Chan, Koon-Ho, et al.
Publicado: (2021) -
Satralizumab for neuromyelitis optica spectrum disorder
Publicado: (2021)